BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 23643881)

  • 1. Inhibition of porcine liver carboxylesterase by phosphorylated flavonoids.
    Wei Y; Peng AY; Huang J
    Chem Biol Interact; 2013 Jul; 204(2):75-9. PubMed ID: 23643881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of phosphorylated flavonoids as potent and selective inhibitors of cholesterol esterase.
    Wei Y; Peng AY; Wang B; Ma L; Peng G; Du Y; Tang J
    Eur J Med Chem; 2014 Mar; 74():751-8. PubMed ID: 23601990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of differential inhibition of hepatic and pancreatic fatty acid ethyl ester synthase by inhibitors of serine-esterases: in vitro and cell culture studies.
    Kaphalia BS; Mericle KA; Ansari GA
    Toxicol Appl Pharmacol; 2004 Oct; 200(1):7-15. PubMed ID: 15451303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and evaluation of flavonoid derivatives as potent AChE inhibitors.
    Sheng R; Lin X; Zhang J; Chol KS; Huang W; Yang B; He Q; Hu Y
    Bioorg Med Chem; 2009 Sep; 17(18):6692-8. PubMed ID: 19692250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective inhibition of carboxylesterases by isatins, indole-2,3-diones.
    Hyatt JL; Moak T; Hatfield MJ; Tsurkan L; Edwards CC; Wierdl M; Danks MK; Wadkins RM; Potter PM
    J Med Chem; 2007 Apr; 50(8):1876-85. PubMed ID: 17378546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new synthesis of fully phosphorylated flavones as potent pancreatic cholesterol esterase inhibitors.
    Peng G; Du Y; Wei Y; Tang J; Peng AY; Rao L
    Org Biomol Chem; 2011 Apr; 9(7):2530-4. PubMed ID: 21340062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and structure-activity relationship studies of flavonoids as inhibitors against human carboxylesterase 2.
    Weng ZM; Ge GB; Dou TY; Wang P; Liu PK; Tian XH; Qiao N; Yu Y; Zou LW; Zhou Q; Zhang WD; Hou J
    Bioorg Chem; 2018 Apr; 77():320-329. PubMed ID: 29421708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of novel benzil (diphenylethane-1,2-dione) analogues as inhibitors of mammalian carboxylesterases.
    Wadkins RM; Hyatt JL; Wei X; Yoon KJ; Wierdl M; Edwards CC; Morton CL; Obenauer JC; Damodaran K; Beroza P; Danks MK; Potter PM
    J Med Chem; 2005 Apr; 48(8):2906-15. PubMed ID: 15828829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and testing of trifluoromethyl-containing phosphonate-peptide conjugates as inhibitors of serine hydrolases.
    Sokolova NV; Nenajdenko VG; Sokolov VB; Serebryakova OG; Makhaeva GF
    Bioorg Med Chem Lett; 2011 Dec; 21(23):7216-8. PubMed ID: 22001085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Esterase metabolism of cholinesterase inhibitors using rat liver in vitro.
    Moser VC; Padilla S
    Toxicology; 2011 Mar; 281(1-3):56-62. PubMed ID: 21237238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphaisocoumarins as a new class of potent inhibitors for pancreatic cholesterol esterase.
    Li B; Zhou B; Lu H; Ma L; Peng AY
    Eur J Med Chem; 2010 May; 45(5):1955-63. PubMed ID: 20149492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flavonoids as human carboxylesterase 2 inhibitors: Inhibition potentials and molecular docking simulations.
    Song SS; Sun CP; Zhou JJ; Chu L
    Int J Biol Macromol; 2019 Jun; 131():201-208. PubMed ID: 30872054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, molecular docking, and biological evaluation of 3-oxo-2-tolylhydrazinylidene-4,4,4-trifluorobutanoates bearing higher and natural alcohol moieties as new selective carboxylesterase inhibitors.
    Makhaeva GF; Elkina NA; Shchegolkov EV; Boltneva NP; Lushchekina SV; Serebryakova OG; Rudakova EV; Kovaleva NV; Radchenko EV; Palyulin VA; Burgart YV; Saloutin VI; Bachurin SO; Richardson RJ
    Bioorg Chem; 2019 Oct; 91():103097. PubMed ID: 31323527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of tricyclic 1,3-oxazin-4-ones and kinetic analysis of cholesterol esterase and acetylcholinesterase inhibition.
    Pietsch M; Gütschow M
    J Med Chem; 2005 Dec; 48(26):8270-88. PubMed ID: 16366609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of human carboxylesterases hCE1 and hiCE by cholinesterase inhibitors.
    Tsurkan LG; Hatfield MJ; Edwards CC; Hyatt JL; Potter PM
    Chem Biol Interact; 2013 Mar; 203(1):226-30. PubMed ID: 23123248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholinesterase inhibitory activities of some flavonoid derivatives and chosen xanthone and their molecular docking studies.
    Khan MT; Orhan I; Senol FS; Kartal M; Sener B; Dvorská M; Smejkal K; Slapetová T
    Chem Biol Interact; 2009 Oct; 181(3):383-9. PubMed ID: 19596285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of flavonoids on acetylcholine esterase: binding and structure-activity relationship.
    Xie Y; Yang W; Chen X; Xiao J
    Food Funct; 2014 Oct; 5(10):2582-9. PubMed ID: 25143139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of flavonoids from various Mediterranean plants on enzymatic activity of intestinal carboxylesterase.
    Stocker P; Yousfi M; Djerridane O; Perrier J; Amziani R; El Boustani S; Moulin A
    Biochimie; 2004 Dec; 86(12):919-25. PubMed ID: 15667942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of helicid analogues as novel acetylcholinesterase inhibitors.
    Wen H; Lin C; Que L; Ge H; Ma L; Cao R; Wan Y; Peng W; Wang Z; Song H
    Eur J Med Chem; 2008 Jan; 43(1):166-73. PubMed ID: 17574306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation of cholinesterase-inhibiting flavonoids from Morus lhou.
    Kim JY; Lee WS; Kim YS; Curtis-Long MJ; Lee BW; Ryu YB; Park KH
    J Agric Food Chem; 2011 May; 59(9):4589-96. PubMed ID: 21434689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.